Obeidat Naser, Khasawneh Ruba, Alrawashdeh Ahmad, Abdel Kareem Ali M, Al-Na'asan Mohammad K, Alkhatatba Mohammad, Bani Essa Suhaib
Department of Diagnostic Radiology and Nuclear Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
Department of Allied Medical Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology, Irbid 22110, Jordan.
Tomography. 2025 May 2;11(5):53. doi: 10.3390/tomography11050053.
Shoulder injury related to vaccine administration (SIRVA), previously observed with influenza vaccines, has gained clinical significance with widespread COVID-19 vaccination. However, few studies correlate vaccine types and demographic factors with the MRI findings of SIRVA. This study aimed to evaluate MRI findings of SIRVA following COVID-19 vaccination and assess associations with vaccine type and patient characteristics.
A retrospective cohort study was conducted on 35 patients with new-onset shoulder complaints within six weeks of COVID-19 vaccination between May 2021 and May 2022. MRI findings suggestive of SIRVA were reviewed, including subacromial bursitis, rotator cuff tears, and adhesive capsulitis. Demographic data, vaccine type, clinical symptoms, and treatments were collected. Follow-up interviews (1-30 September 2024) assessed symptom persistence and vaccine hesitancy. Descriptive statistics and Chi-square tests were used to explore associations.
Of the 35 patients (mean age 53.6 ± 9.0 years; 54.3% female), subacromial bursitis was the most common MRI finding (89.5%), followed by tendonitis (47.4%) and adhesive capsulitis (36.8%). Tendonitis correlated with older age ( = 0.024) and AstraZeneca vaccination ( = 0.033). Subacromial bursitis was linked to female sex ( = 0.013) and higher BMI ( = 0.023). Adhesive capsulitis was associated with receiving the Sinopharm vaccine ( = 0.029). Persistent symptoms (22.9%) were more common in younger patients, women, and those with right-sided injections.
SIRVA following COVID-19 vaccination showed different MRI patterns associated with female sex, higher BMI, and vaccine type. Awareness of these patterns may expedite recognition of COVID-19-associated SIRVA in routine practice.
与疫苗接种相关的肩部损伤（SIRVA）此前在流感疫苗接种时就已被观察到，随着新冠病毒疫苗的广泛接种，其具有了临床意义。然而，很少有研究将疫苗类型和人口统计学因素与SIRVA的磁共振成像（MRI）结果相关联。本研究旨在评估新冠病毒疫苗接种后SIRVA的MRI表现，并评估其与疫苗类型和患者特征的关联。
对2021年5月至2022年5月期间在新冠病毒疫苗接种后六周内出现新发肩部不适的35例患者进行了一项回顾性队列研究。对提示SIRVA的MRI表现进行了评估，包括肩峰下滑囊炎、肩袖撕裂和粘连性关节囊炎。收集了人口统计学数据、疫苗类型、临床症状和治疗情况。随访访谈（2024年9月1日至30日）评估了症状持续情况和疫苗犹豫情况。使用描述性统计和卡方检验来探索关联。
在35例患者中（平均年龄53.6±9.0岁；54.3%为女性），肩峰下滑囊炎是最常见的MRI表现（89.5%），其次是肌腱炎（47.4%）和粘连性关节囊炎（36.8%）。肌腱炎与年龄较大（P = 0.024）和接种阿斯利康疫苗（P = 0.033）相关。肩峰下滑囊炎与女性性别（P = 0.013）和较高的体重指数（BMI）（P = 0.023）有关。粘连性关节囊炎与接种国药疫苗（P = 0.029）相关。持续症状（22.9%）在年轻患者、女性以及接受右侧注射的患者中更为常见。
新冠病毒疫苗接种后的SIRVA表现出与女性性别、较高BMI和疫苗类型相关的不同MRI模式。了解这些模式可能有助于在常规实践中更快地识别与新冠病毒相关的SIRVA。
